BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 30782737)

  • 1. Combination of the National Early Warning Score (NEWS) and inflammatory biomarkers for early risk stratification in emergency department patients: results of a multinational, observational study.
    Eckart A; Hauser SI; Kutz A; Haubitz S; Hausfater P; Amin D; Amin A; Huber A; Mueller B; Schuetz P
    BMJ Open; 2019 Jan; 9(1):e024636. PubMed ID: 30782737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
    Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
    Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study.
    Schuetz P; Hausfater P; Amin D; Amin A; Haubitz S; Faessler L; Kutz A; Conca A; Reutlinger B; Canavaggio P; Sauvin G; Bernard M; Huber A; Mueller B;
    Crit Care; 2015 Oct; 19():377. PubMed ID: 26511878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.
    Saeed K; Wilson DC; Bloos F; Schuetz P; van der Does Y; Melander O; Hausfater P; Legramante JM; Claessens YE; Amin D; Rosenqvist M; White G; Mueller B; Limper M; Callejo CC; Brandi A; Macchi MA; Cortes N; Kutz A; Patka P; Yañez MC; Bernardini S; Beau N; Dryden M; van Gorp ECM; Minieri M; Chan L; Rood PPM; Del Castillo JG
    Crit Care; 2019 Feb; 23(1):40. PubMed ID: 30736862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are admission procalcitonin levels universal mortality predictors across different medical emergency patient populations? Results from the multi-national, prospective, observational TRIAGE study.
    Sager R; Wirz Y; Amin D; Amin A; Hausfater P; Huber A; Haubitz S; Kutz A; Mueller B; Schuetz P
    Clin Chem Lab Med; 2017 Oct; 55(12):1873-1880. PubMed ID: 28412721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
    Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
    Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
    Travaglino F; De Berardinis B; Magrini L; Bongiovanni C; Candelli M; Silveri NG; Legramante J; Galante A; Salerno G; Cardelli P; Di Somma S
    BMC Infect Dis; 2012 Aug; 12():184. PubMed ID: 22874067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.
    Nickel CH; Messmer AS; Geigy N; Misch F; Mueller B; Dusemund F; Hertel S; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2013 Jul; 20(7):670-9. PubMed ID: 23859580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
    Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
    Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study.
    Graziadio S; O'Leary RA; Stocken DD; Power M; Allen AJ; Simpson AJ; Price DA
    BMJ Open; 2019 Feb; 8(11):e020337. PubMed ID: 30798282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-Regional Pro-Adrenomedullin in Combination With Pediatric Early Warning Scores for Risk Stratification of Febrile Children Presenting to the Emergency Department: Secondary Analysis of a Nonprespecified United Kingdom Cohort Study.
    Lenihan RAF; Ang J; Pallmann P; Romaine ST; Waldron CA; Thomas-Jones E; Miah N; Carrol ED
    Pediatr Crit Care Med; 2022 Dec; 23(12):980-989. PubMed ID: 36239515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does mid-regional pro-adrenomedullin (MR-proADM) improve the sequential organ failure assessment-score (SOFA score) for mortality-prediction in patients with acute infections? Results of a prospective observational study.
    Haag E; Gregoriano C; Molitor A; Kloter M; Kutz A; Mueller B; Schuetz P
    Clin Chem Lab Med; 2021 May; 59(6):1165-1176. PubMed ID: 33554514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of the National Early Warning Score-Lactate for mortality and the need for critical care among general emergency department patients.
    Jo S; Yoon J; Lee JB; Jin Y; Jeong T; Park B
    J Crit Care; 2016 Dec; 36():60-68. PubMed ID: 27546749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study.
    Dres M; Hausfater P; Foissac F; Bernard M; Joly LM; Sebbane M; Philippon AL; Gil-Jardiné C; Schmidt J; Maignan M; Treluyer JM; Roche N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1047-1056. PubMed ID: 28408815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.
    Gregoriano C; Koch D; Kutz A; Haubitz S; Conen A; Bernasconi L; Hammerer-Lercher A; Saeed K; Mueller B; Schuetz P
    Clin Chem Lab Med; 2021 Apr; 59(5):995-1004. PubMed ID: 33554516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of combining inflammatory biomarkers and clinical scales in an emergency department to stratify risk in patients with infections.
    Clemente C; Fuentes Ferrer ME; Ortega Heredia D; Julián Jiménez A; Martín-Sánchez FJ; González Del Castillo J
    Emergencias; 2024 Jan; 36(1):9-16. PubMed ID: 38318737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia.
    Renaud B; Schuetz P; Claessens YE; Labarère J; Albrich W; Mueller B
    Chest; 2012 Dec; 142(6):1447-1454. PubMed ID: 22661450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
    Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
    Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR- proADM to detect specific types of organ failure in infection.
    Andrés C; Andaluz-Ojeda D; Cicuendez R; Nogales L; Martín S; Martin-Fernandez M; Almansa R; Calvo D; Esteban-Velasco MC; Vaquero-Roncero LM; Ríos-Llorente A; Sanchez-Barrado E; Muñoz-Bellvís L; Aldecoa C; Bermejo-Martin JF
    Eur J Clin Invest; 2020 Jun; 50(6):e13246. PubMed ID: 32307701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
    Bernal-Morell E; García-Villalba E; Vera MDC; Medina B; Martinez M; Callejo V; Valero S; Cinesi C; Piñera P; Alcaraz A; Marin I; Muñoz A; Cano A
    J Infect; 2018 Mar; 76(3):249-257. PubMed ID: 29246637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.